Monza

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Primary biliary cholangitis1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• GlaxoSmithKline2 trials

Running trials

• Active, not recruiting

  Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease

  NCT04915755· Phase 3· GlaxoSmithKline· Source

• Active, not recruiting

  Linerixibat Long-term Safety, and Tolerability Study

  NCT04167358· Phase 3· GlaxoSmithKline· Source